Effects of AMPA/kainate receptor blockade on responses to dopamine receptor agonists in the core and shell of the rat nucleus accumbens

Psychopharmacology

Volumn 150, Issue 1, 2000, Pages 102-111

  Choi, K H ^a   Zarandi, B ^a   Todd, K G ^a   Biondo, A M ^a   Greenshaw, A J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

7 OH DPAT; AMPA kainate; CNQX; Core shell; Dopamine; Locomotor activity; NBQX; Nucleus accumbens; Quinpirole; SKF 38393

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE RECEPTOR STIMULATING AGENT; KAINIC ACID RECEPTOR ANTAGONIST; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; DOPAMINE AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; TETRAHYDRONAPHTHALENES;

EID: 0034089416     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000391     Document Type: Article

References (50)

1. Allison K, Ivanová S, Greenshaw AJ (1995) Behavioural response to SKF 38392 and quinpirole following chronic antidepressant treatment. Eur J Pharmacol 277:139-144
2. Bubser M, Tzschentke T, Hauber W (1995) Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats. J Neural Transm 101:115-126
3. Bunney BG, Bunney Jr. WE, Carlsson A (1995) Schizophrenia and glutamate. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 1205-1214
4. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115:516-528
5. Carlezon WA Jr, Wise RA (1996a) Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 16:3112-3122
6. Carlezon WA Jr, Wise RA (1996b) Microinjections of phencyclidine (PCP) and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward. Psychopharmacology 128:413-420
7. Dalia A, Uretsky NJ, Wallace LJ (1998) Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res 788: 111-117
8. Danysz W, Essmann U, Bresink I, Wilke R (1994) Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol Biochem Behav 48:111-118
9. Deutch AY, Bourdelais AJ, Zahm DS (1993) The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Kalivas PW, Barnes CD (eds) Limbic motor circuits and neuropsychiatry. CRC Press, Boca Raton, FL, pp 45-88
10. Diaz J, Levesque D, Griffon N, Lammers CH, Martres M-P, Sokoloff P, Schwartz J-C (1994) Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 6:1384-1387
11. Dreher JK, Jackson DM (1989) Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 487:267-277
12. Essman WD, McGonigle P, Lucki I (1993) Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology 112:233-241
13. Gerfen CR, Young WS 3rd (1988) Distribution of striatonigral and striatopallidal peptidergic neurones in both patch and matrix compartments: an in situ hybridisation histochemistry and fluorescent retrograde tracing study. Brain Res 460:161-167
14. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250:1429-1432
15. Gilbert DB, Cooper SJ (1995) 7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects? Pharmacol Biochem Behav 52: 275-280
16. Gong W, Neill DB, Lynn M, Justice JB Jr (1999) Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93:1349-1358
17. Greenshaw AJ (1997) A simple technique for determining stereo-taxic coordinates for brain implantation for probes at rotated angles in one or two planes. J Neurosci Methods 78:169-172
18. Greenshaw AJ, Ivanova S, Zarandi B, Allison K (1995) Dopamine D3 agonist (7-OHDPAT) effects in tests of mesolimbic reward and locomotion. Proceedings of the XIXth Congress of the Collegium Internationale Neuropsychopharmacologium, Kyoto, Japan
19. Groenewegen HJ, Wright CI, Beijer AV, Voorn P (1999) Convergence and segregation of ventral striatal inputs and outputs. Ann N Y Acad Sci 877:49-63
20. Harvey J, Lacey MG (1997) A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release. J Neurosci 17:5271-5280
21. Hauber W, Andersen R (1993) The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anti-cataleptic activity induced by the NMDA receptor antagonist dizocilpine. Naunyn Schmiedeberg's Arch Pharmacol 348:486-490
22. Heimer L, Zahm DS, Churchill L, Kalivas PW, Wohltmann C (1991) Specificity in the projection patterns of accumbal core and shell. Neuroscience 41:89-126
23. Heimer L, Alheid GF, de Olmos JS, Groenewegen HJ, Haber SN, Halan RE, Zahm DS (1997) The accumbens: beyond the core-shell dichotomy. J Neuropsychiatry Clin Neurosci 9:354-381
24. Kaddis FG, Wallace LJ, Uretsky NJ (1993) AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory responses to cocaine and dopamine agonists. Pharmacol Biochem Behav 46:703-708
25. Kalivas PW, Duffy P (1997) Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 761:173-177
26. Kitamura M, Koshikawa N, Yoneshige N, Cools AR (1999) Behavioural and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats. Neuropharmacology 38:1397-1407
27. Koshikawa N, Kitamura M, Kobayashi M, Cools AR (1996) Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology 126:185-190
28. Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426
29. Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME (1997) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioural sensitisation to cocaine and amphetamine. Psychopharmacology 134:266-276
30. Mead AN, Stephens DN (1999) CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors. J Pharmacol Exp Ther 290:9-15
31. Meyer ME (1996) Mesolimbic 7-OH-DPAT affects locomotor activities in rats. Pharmacol Biochem Behav 55:209-214
32. Neve KA, Neve RL (1997) Molecular biology of dopamine receptors. In: Neve KA, Neve RL (eds) The dopamine receptors. Humana Press, Totowa, NJ, pp 27-76
33. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
34. Ridray S, Griffon N, Mignon V, Souil E, Carboni S, Diaz J, Schwartz J-C, Sokoloff P (1998) Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 10:1676-1686
35. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990) 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571-574
36. Stephens DN, Cole BJ (1996) AMPA antagonists differ from NMDA antagonists in their effects on operant DRL and delayed matching to position tasks. Psychopharmacology 126:249-259
37. Svensson A, Carlsson A, Carlsson ML (1992) Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. J Neural Transm 90:199-217
38. Svensson A, Carlsson ML, Carlsson A (1994a) Glutamatergic neurones projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone. Prog Neuropsychopharmacol Biol Psychiatry 18: 1203-1218
39. Svensson A, Carlsson A, Huff RM, Kling-Petersen T, Waters N (1994b) Behavioural and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Eur J Pharmacol 263:235-243
40. Svensson A, Carlsson ML, Carlsson A (1995) Crucial role of the nucleus accumbens in the neurotransmitter interactions regulating motor control in mice. J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect 101:127-148
41. Swanson CJ, Heath S, Stratford TR, Kelley AE (1997) Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 58:933-945
42. Thorn L, Ashmeade TE, Storey VJ, Routledge C, Reavill C (1997) Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic D2 or D3 receptors. Neuropharmacology 36:787-792
43. Vanover KE (1998) Effects of AMPA receptor antagonists on dopamine-mediated behaviours in mice. Psychopharmacology 136:123-131
44. Waddington J, Daly SA, Downs RP, Deveney AM, McCauley PG, O'Boyle KM (1995) Behavioural pharmacology of D1-like dopamine receptors: further subtyping, new pharmacological probes and interactions with D2-like receptors. Prog Neuropsychopharmacol Biol Psychiatry 19:811-831
45. Wan FJ, Swerdlow NR (1996) Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell sub-regions. Brain Res 722: 168-176
46. Waters N, Svensson K, Haadsma-Svensson S, Smith MW, Carlsson A (1993) The dopamine D3 receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Basic Neurosci Neurol Sect Psychiatry Sect 94:11-19
47. Willins DL, Narayanan S, Wallace LJ, Uretsky NJ (1993) The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmacol Biochem Behav 46:881-887
48. Wong AC, Shetreat ME, Clarke JO, Rayport S (1999) D1-and D2-like dopamine receptors are co-localised on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 89:221-233
49. Zahm DS (1999) Functional-anatomical implications of the nucleus accumbens core and shell subterritoties. Ann NY Acad Sci 877:113-128
50. 3 DA agonist (thesis). University of Alberta, Edmonton, Canada